
Loading, please wait...

Loading, please wait...

Adjunctive corticosteroids are standard in many patients with tuberculous meningitis, but the evidence base in people with HIV-associated disease has been less certain. In a double-blind randomized trial of 520 HIV-positive adults with TB meningitis, dexamethasone was compared with placebo in addition to 12 months of antituberculous therapy. During one year of follow-up, mortality was not significantly different between the dexamethasone and placebo groups, and prespecified subgroup analyses did not identify a population with a clear survival benefit. Serious adverse events were also similar. The findings are clinically important because they show that evidence from HIV-negative TB meningitis cannot automatically be extrapolated to people living with HIV. For HCPs, treatment decisions should therefore follow disease-specific guidance and consider immune status, opportunistic infections and the risk of immune reconstitution inflammatory syndrome. The study also illustrates why apparently universal treatment practices may require separate evidence in immunocompromised populations. This is directly aligned with IANCON's focus on neuroinfections and neurological complications of systemic infection.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Adjunctive corticosteroids are standard in many patients with tuberculous meningitis, but the evidence base in people with HIV-associated disease has been less certain. In a double-blind randomized trial of 520 HIV-positive adults with TB meningitis, dexamethasone was compared with placebo in addition to 12 months of antituberculous therapy. During one year of follow-up, mortality was not significantly different between the dexamethasone and placebo groups, and prespecified subgroup analyses did not identify a population with a clear survival benefit. Serious adverse events were also similar. The findings are clinically important because they show that evidence from HIV-negative TB meningitis cannot automatically be extrapolated to people living with HIV. For HCPs, treatment decisions should therefore follow disease-specific guidance and consider immune status, opportunistic infections and the risk of immune reconstitution inflammatory syndrome. The study also illustrates why apparently universal treatment practices may require separate evidence in immunocompromised populations. This is directly aligned with IANCON's focus on neuroinfections and neurological complications of systemic infection.
4 weeks back

A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
3 days back

Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back

Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
4 days back

A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back

Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back